Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001125282-05-005146
Filing Date
2005-10-04
Accepted
2005-10-04 17:29:08
Documents
1
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 form.html 4  
1 form.xml 4 3866
  Complete submission text file 0001125282-05-005146.txt   5861
Mailing Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422
Business Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422 2152836850
INKINE PHARMACEUTICAL CO INC (Issuer) CIK: 0000929547 (see all company filings)

EIN.: 133754005 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INKINE PHARMACEUTICAL COMPANY, INC. 1787 SENTRY PARKWAY W., BLDG 18, STE 440 BLUE BELL PA 19422
Business Address 215-283-6853
Cullen John (Reporting) CIK: 0001316741 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25572 | Film No.: 051122788